Skip to main content
Evotic gains $5M in neurodegenerative diseases deal with Celgene

Celgene gave Evotec a $5 million milestone payment from a 10-month-old collaboration to study neurodegenerative diseases. The payment was related to the successful completion of a screening campaign using an induced pluripotent stem cell-based screening platform from Evotec.

Full Story: